Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 9.921 Q1 | 391 | 246 | 676 | 7779 | 8579 | 315 | 12.40 | 31.62 | 35.95 | |
2 | Pharmacological Reviews | journal | 8.176 Q1 | 254 | 26 | 65 | 10316 | 1412 | 65 | 22.15 | 396.77 | 37.50 | |
3 | Nano Today | journal | 5.586 Q1 | 175 | 128 | 153 | 15010 | 2993 | 153 | 19.62 | 117.27 | 35.83 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 5.060 Q1 | 117 | 508 | 582 | 19284 | 7039 | 571 | 11.60 | 37.96 | 41.40 | |
5 | Annual Review of Pharmacology and Toxicology | journal | 4.968 Q1 | 224 | 33 | 90 | 4408 | 1273 | 90 | 13.16 | 133.58 | 38.60 | |
6 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | 44.51 | |
7 | Trends in Pharmacological Sciences | journal | 3.878 Q1 | 244 | 101 | 288 | 6920 | 3228 | 276 | 10.11 | 68.51 | 34.74 | |
8 | Molecular Therapy | journal | 3.871 Q1 | 209 | 242 | 707 | 11663 | 6646 | 656 | 8.56 | 48.19 | 41.71 | |
9 | Advanced Drug Delivery Reviews | journal | 3.475 Q1 | 366 | 137 | 485 | 28532 | 7293 | 443 | 13.84 | 208.26 | 37.45 | |
10 | Pharmacology and Therapeutics | journal | 3.461 Q1 | 233 | 151 | 450 | 30790 | 5501 | 450 | 11.71 | 203.91 | 40.18 | |
11 | Cell Chemical Biology | journal | 3.364 Q1 | 206 | 154 | 527 | 9455 | 3584 | 515 | 6.41 | 61.40 | 36.71 | |
12 | Protein and Cell | journal | 2.973 Q1 | 94 | 95 | 308 | 3915 | 1901 | 194 | 6.45 | 41.21 | 41.31 | |
13 | Cellular and Molecular Life Sciences | journal | 2.928 Q1 | 261 | 313 | 876 | 35261 | 7378 | 869 | 8.64 | 112.65 | 43.14 | |
14 | Medicinal Research Reviews | journal | 2.868 Q1 | 150 | 81 | 162 | 16520 | 2023 | 160 | 12.29 | 203.95 | 36.31 | |
15 | Neuropsychopharmacology | journal | 2.704 Q1 | 249 | 285 | 891 | 16878 | 5532 | 810 | 5.73 | 59.22 | 45.32 | |
16 | Natural Product Reports | journal | 2.703 Q1 | 211 | 78 | 200 | 12856 | 2264 | 193 | 11.27 | 164.82 | 23.77 | |
17 | npj Vaccines | journal | 2.691 Q1 | 47 | 105 | 134 | 5348 | 869 | 133 | 6.16 | 50.93 | 44.39 | |
18 | Theranostics | journal | 2.689 Q1 | 158 | 827 | 1327 | 56741 | 14448 | 1307 | 10.67 | 68.61 | 39.58 | |
19 | Pain | journal | 2.524 Q1 | 296 | 310 | 942 | 14068 | 5518 | 796 | 5.77 | 45.38 | 44.93 | |
20 | Neurotherapeutics | journal | 2.496 Q1 | 136 | 154 | 292 | 13488 | 2091 | 270 | 6.61 | 87.58 | 43.50 | |
21 | Emerging Microbes and Infections | journal | 2.475 Q1 | 94 | 302 | 489 | 10395 | 2907 | 413 | 6.02 | 34.42 | 41.11 | |
22 | British Journal of Pharmacology | journal | 2.432 Q1 | 244 | 364 | 1008 | 26207 | 7736 | 951 | 7.18 | 72.00 | 42.67 | |
23 | Emerging Contaminants | journal | 2.343 Q1 | 36 | 46 | 53 | 2977 | 496 | 52 | 3.89 | 64.72 | 35.37 | |
24 | Advanced healthcare materials | journal | 2.288 Q1 | 140 | 332 | 992 | 26712 | 9011 | 973 | 9.19 | 80.46 | 36.59 | |
25 | ACS Pharmacology and Translational Science | journal | 2.271 Q1 | 36 | 132 | 64 | 8523 | 223 | 56 | 3.48 | 64.57 | 38.38 | |
26 | Nucleic Acid Therapeutics | journal | 2.255 Q1 | 77 | 38 | 115 | 1567 | 613 | 113 | 5.01 | 41.24 | 39.10 | |
27 | Molecular Therapy - Nucleic Acids | journal | 2.208 Q1 | 95 | 345 | 652 | 17486 | 5091 | 647 | 8.06 | 50.68 | 42.86 | |
28 | Environmental Pollution | journal | 2.136 Q1 | 301 | 2106 | 4199 | 130310 | 35888 | 4164 | 8.14 | 61.88 | 41.25 | |
29 | Journal of Antimicrobial Chemotherapy | journal | 2.124 Q1 | 221 | 525 | 1711 | 15296 | 8485 | 1490 | 4.78 | 29.14 | 48.78 | |
30 | Journal of Controlled Release | journal | 2.119 Q1 | 313 | 540 | 1470 | 47197 | 13536 | 1392 | 9.01 | 87.40 | 41.04 | |
31 | Antimicrobial Agents and Chemotherapy | journal | 2.070 Q1 | 289 | 743 | 2638 | 26662 | 13257 | 2505 | 4.61 | 35.88 | 43.82 | |
32 | Antiviral Research | journal | 2.052 Q1 | 151 | 211 | 683 | 10804 | 4079 | 683 | 5.93 | 51.20 | 43.59 | |
33 | Journal of Medicinal Chemistry | journal | 2.010 Q1 | 301 | 908 | 2117 | 60829 | 14507 | 2103 | 6.88 | 66.99 | 36.86 | |
34 | PLoS Neglected Tropical Diseases | journal | 1.990 Q1 | 163 | 962 | 2477 | 46862 | 11533 | 2431 | 4.30 | 48.71 | 43.21 | |
35 | Expert Opinion on Therapeutic Targets | journal | 1.964 Q1 | 106 | 103 | 291 | 12152 | 1629 | 257 | 5.41 | 117.98 | 40.66 | |
36 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | 44.61 | |
37 | Clinical Pharmacology and Therapeutics | journal | 1.941 Q1 | 209 | 323 | 902 | 10846 | 4184 | 682 | 4.28 | 33.58 | 39.71 | |
38 | BioDrugs | journal | 1.919 Q1 | 79 | 62 | 166 | 4406 | 981 | 155 | 4.90 | 71.06 | 37.85 | |
39 | Acta Pharmaceutica Sinica B | journal | 1.912 Q1 | 99 | 184 | 274 | 13417 | 2638 | 260 | 10.76 | 72.92 | 41.78 | |
40 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 51 | 308 | 3211 | 1584 | 299 | 4.77 | 62.96 | 37.23 | |
41 | Current Opinion in Pharmacology | journal | 1.868 Q1 | 148 | 107 | 343 | 6500 | 1820 | 306 | 5.05 | 60.75 | 42.81 | |
42 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | 42.93 | |
43 | Pharmacological Research | journal | 1.850 Q1 | 169 | 598 | 1048 | 58728 | 7342 | 971 | 6.90 | 98.21 | 44.02 | |
44 | PharmacoEconomics | journal | 1.809 Q1 | 118 | 112 | 359 | 4864 | 1371 | 314 | 3.77 | 43.43 | 42.63 | |
45 | Journal of Immunotherapy | journal | 1.805 Q1 | 106 | 46 | 147 | 1371 | 734 | 147 | 4.52 | 29.80 | 44.44 | |
46 | Drug and Alcohol Dependence | journal | 1.783 Q1 | 187 | 539 | 1407 | 24856 | 6246 | 1398 | 4.15 | 46.12 | 51.93 | |
47 | Drug Discovery Today | journal | 1.778 Q1 | 215 | 249 | 666 | 18949 | 5285 | 629 | 7.37 | 76.10 | 37.49 | |
48 | Neuropharmacology | journal | 1.760 Q1 | 191 | 417 | 1332 | 35128 | 6810 | 1306 | 4.79 | 84.24 | 45.07 | |
49 | npj Systems Biology and Applications | journal | 1.752 Q1 | 35 | 33 | 114 | 1694 | 498 | 114 | 4.37 | 51.33 | 27.05 | |
50 | Particle and Fibre Toxicology | journal | 1.748 Q1 | 119 | 61 | 145 | 4821 | 1293 | 143 | 8.71 | 79.03 | 45.32 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®